Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management

Epidermal growth factor inhibitors (EGFRI), the first targeted cancer therapy, are currently an essential treatment for many advance-stage epithelial cancers. These agents have the superior ability to target cancers cells and better safety profile compared to conventional chemotherapies. However, cu...

Full description

Saved in:
Bibliographic Details
Main Authors: K. Chanprapaph (Author), V. Vachiramon (Author), P. Rattanakaemakorn (Author)
Format: Book
Published: Hindawi Limited, 2014-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available